+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Therapy Market - Global Forecast 2025-2030- Product Image
Cell Therapy Market - Global Forecast 2025-2030- Product Image
Sale

Cell Therapy Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989916
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell therapy continues to advance as a critical force in transforming healthcare, delivering innovative solutions in regenerative medicine and targeted disease intervention. With evolving technologies, expanded clinical applications, and a dynamic regulatory environment, the cell therapy market offers compelling opportunities for strategic growth and long-term value creation for stakeholders.

Market Snapshot: Cell Therapy Market Size and Growth

The global cell therapy market grew from USD 9.60 billion in 2024 to USD 10.64 billion in 2025, and it is forecast to expand at a CAGR of 10.94%, reaching USD 17.91 billion by 2030. Strong momentum is driven by rising demand for advanced immunotherapies, expanding clinical indications, and the integration of digital health innovations. Strategic investments across key regions are fostering competitive differentiation and accelerating the pace of cell-based product launches.

Scope & Segmentation: Understanding Cell Therapy Market Dimensions

This report provides comprehensive segmentation and market coverage, offering clarity on all critical market subsets and regions:

  • Cell Types: Non-stem cells (including CAR-T, dendritic, and NK cells); Stem cells (including embryonic, hematopoietic, and mesenchymal variants).
  • Therapy Approaches: Allogenic strategies for broader scalability; Autologous solutions designed for personalized medicine and rare conditions.
  • Administration Routes: Intramuscular, intratumoral, and intravenous delivery, each supporting unique clinical objectives.
  • Application Areas: Autoimmune disorders (such as multiple sclerosis and rheumatoid arthritis); cancer treatments (targeting both hematologic malignancies and solid tumors); infectious diseases (bacterial and viral); regenerative medicine.
  • End Users: Academic and research institutes, clinics, commercial laboratories, and hospitals, covering innovation to patient delivery.
  • Regional Coverage:
    Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina)
    Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland)
    Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Notably including Anterogen, Astellas Pharma, Athersys, BioNTech, Bristol-Myers Squibb, Castle Creek Biosciences, Catalent, FUJIFILM Holdings, Gilead Sciences, JCR Pharmaceuticals, Kolon TissueGene, Lonza, Medipost, Mesoblast, Novartis, NuVasive, Pfizer, Sartorius, Stemedica Cell Technologies, Stempeutics Research, Takeda, TegoScience, Thermo Fisher Scientific, Vericel Corporation.

Technologies Propelling Market Evolution

  • Gene Editing: CRISPR-driven advancements accelerate development of immune effector cells and enable novel therapeutic profiles.
  • Biomaterials & Scaffold Innovation: New scaffold technologies support engraftment and tissue regeneration, broadening cell therapy applications.
  • Digital Integration: Real-world data analytics and remote patient monitoring drive adaptive trials and improve patient outcomes.

Key Takeaways for Senior Decision-Makers

  • Advanced manufacturing and robust digital health integration are optimizing operational efficiencies, enabling agile response to market changes.
  • Stakeholders should align strategies with evolving compliance frameworks as global regulators refine accelerated approval pathways.
  • Allogeneic modalities offer supply chain scalability, while autologous approaches remain critical for personalization and rare disease coverage.
  • Collaborative alliances between commercial entities and academic institutions are accelerating translational research and market commercialization.
  • Regional adaptation is essential, as diverse policy frameworks, reimbursement routes, and infrastructural investments influence adoption patterns and competitive positioning.
  • Sponsoring organizations investing in flexible, digital-enabled operations are poised to bring new therapies to market ahead of traditional development cycles.

Tariff Impact: Navigating Shifting U.S. Trade Policies

Recent U.S. tariff policies have introduced considerable pressures on the global cell therapy supply chain. Elevated duties on imported reagents and single-use bioprocessing components have prompted businesses to revise procurement, focus on domestic and nearshoring options, and invest in vertical integration for reagents and vector manufacturing. Companies are fostering supplier diversification and forming consortia to offset cost increases while actively seeking tariff exemptions to ensure continued access to critical biologics.

Methodology & Data Sources

This analysis draws on a blend of primary interviews with industry executives, clinicians, and regulatory experts, complemented by extensive secondary research including peer-reviewed journals, white papers, and sector publications. Data triangulation and scenario analysis underpin the rigor and reliability of the findings.

Why This Report Matters

  • Enables executive teams to prioritize high-value segments, adapt to regulatory developments, and benchmark against leading competitors.
  • Delivers actionable strategies for supply chain resilience, clinical deployment, and regional expansion tailored to the unique dynamics of each market.

Conclusion

The cell therapy market is defined by regulatory agility, collaborative innovation, and technology-driven transformation. Leveraging segmented insights and strategic recommendations, stakeholders can shape their path in this evolving and high-growth industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid emergence of allogeneic off-the-shelf CAR-T therapies with standardized dosing and reduced manufacturing timelines
5.2. Integration of automated closed-loop bioreactor systems for scalable cell therapy production and quality control
5.3. Application of CRISPR gene editing to engineer next generation universal donor T cells with enhanced tumor specificity
5.4. Implementation of decentralized point-of-care manufacturing to streamline autologous cell therapy delivery to remote treatment centers
5.5. Adoption of artificial intelligence-driven analytics for real-time potency assessment and release criteria optimization in cell therapies
5.6. Expansion of cell therapy indications into solid tumor treatments through tumor microenvironment modulation strategies
5.7. Development of combination regimens combining cell therapies with immune checkpoint inhibitors to improve durable response rates
5.8. Establishment of global regulatory harmonization frameworks to accelerate clinical adoption and market authorization of cell treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Therapy Market, by Type
8.1. Introduction
8.2. Non-stem Cells
8.2.1. CAR-T Cells
8.2.2. Dendritic Cells
8.2.3. NK Cells
8.3. Stem Cells
8.3.1. Embryonic Stem Cells
8.3.2. Hematopoietic Stem Cell
8.3.3. Mesenchymal Stem Cell
9. Cell Therapy Market, by Therapy Type
9.1. Introduction
9.2. Allogenic
9.3. Autologous
10. Cell Therapy Market, by Mode of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intratumoral
10.4. Intravenous
11. Cell Therapy Market, by Application
11.1. Introduction
11.2. Autoimmune Disorders
11.2.1. Multiple Sclerosis
11.2.2. Rheumatoid Arthritis
11.3. Cancer Treatment
11.3.1. Hematologic Malignancies
11.3.2. Solid Tumors
11.4. Infectious Diseases
11.4.1. Bacterial Infections
11.4.2. Viral Infections
11.5. Regenerative Medicine
12. Cell Therapy Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Clinics
12.4. Commercial Laboratories
12.5. Hospitals
13. Americas Cell Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cell Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cell Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Anterogen Co., Ltd.
16.3.2. Astellas Pharma Inc.
16.3.3. Athersys, Inc.
16.3.4. BioNTech SE
16.3.5. Bristol-Myers Squibb Company
16.3.6. Castle Creek Biosciences, Inc.
16.3.7. Catalent, Inc.
16.3.8. FUJIFILM Holdings Corporation
16.3.9. Gilead Sciences, Inc.
16.3.10. JCR Pharmaceuticals Co., Ltd.
16.3.11. Kolon TissueGene, Inc.
16.3.12. Lonza Group Ltd.
16.3.13. Medipost Co., Ltd.
16.3.14. Mesoblast Ltd.
16.3.15. Novartis AG
16.3.16. NuVasive, Inc.
16.3.17. Pfizer Inc.
16.3.18. Sartorius AG
16.3.19. Stemedica Cell Technologies, Inc.
16.3.20. Stempeutics Research Pvt. Ltd.
16.3.21. Takeda Pharmaceutical Company Limited
16.3.22. TegoScience
16.3.23. Thermo Fisher Scientific, Inc.
16.3.24. Vericel Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL THERAPY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CELL THERAPY MARKET: RESEARCHAI
FIGURE 26. CELL THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 27. CELL THERAPY MARKET: RESEARCHCONTACTS
FIGURE 28. CELL THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY CAR-T CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY CAR-T CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY NK CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY NK CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL THERAPY MARKET SIZE, BY INTRATUMORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL THERAPY MARKET SIZE, BY INTRATUMORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CELL THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CELL THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CELL THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CELL THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CELL THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CELL THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CELL THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CELL THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CELL THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CELL THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CELL THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CELL THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CELL THERAPY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CELL THERAPY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 130. CANADA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 131. CANADA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 132. CANADA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 133. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 140. CANADA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 141. CANADA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 142. CANADA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 143. CANADA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 144. CANADA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 145. CANADA CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. GERMANY CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. FRANCE CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. FRANCE CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 284. FRANCE CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 285. FRANCE CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 286. FRANCE CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. ITALY CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 310. ITALY CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 311. ITALY CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 312. ITALY CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 313. ITALY CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 314. ITALY CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 315. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. ITALY CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. ITALY CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 322. ITALY CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 323. ITALY CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 324. ITALY CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 325. ITALY CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 326. ITALY CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 327. ITALY CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. ITALY CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. SPAIN CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 330. SPAIN CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 331. SPAIN CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 332. SPAIN CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 333. SPAIN CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 334. SPAIN CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 335. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 336. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 337. SPAIN CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 338. SPAIN CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 339. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. SPAIN CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 342. SPAIN CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 343. SPAIN CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2024 (USD MILLION)
TABLE 344. SPAIN CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2025-2030 (USD MILLION)
TABLE 345. SPAIN CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 346. SPAIN CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 347. SPAIN CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. SPAIN CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2024 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • Athersys, Inc.
  • BioNTech SE
  • Bristol-Myers Squibb Company
  • Castle Creek Biosciences, Inc.
  • Catalent, Inc.
  • FUJIFILM Holdings Corporation
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • Lonza Group Ltd.
  • Medipost Co., Ltd.
  • Mesoblast Ltd.
  • Novartis AG
  • NuVasive, Inc.
  • Pfizer Inc.
  • Sartorius AG
  • Stemedica Cell Technologies, Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • TegoScience
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.91 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Allogeneic Cell Therapy Market - Global Forecast 2025-2030 - Product Image

Allogeneic Cell Therapy Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Autologous Cell Therapies Market - Global Forecast 2025-2030 - Product Image

Autologous Cell Therapies Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033 - Product Image

Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033

  • Report
  • 138 Pages
  • Global
From
Cell Therapy Technologies Market Size, Share & Trends Analysis Report by Product (Raw Materials, Instruments), Workflow (Separation, Expansion), Cell Type (T-Cells, Stem Cells), End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Cell Therapy Technologies Market Size, Share & Trends Analysis Report by Product (Raw Materials, Instruments), Workflow (Separation, Expansion), Cell Type (T-Cells, Stem Cells), End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.